Barely Significant
← all excerpts

Pretreatment prostate specific antigen doubling time as prognostic factor in prostate cancer patients.

Oncoscience · 2017 · PMC5361642 · PMID 28484728

Europe PMCDOI
1
hedged sentence
0.0000
closest p · 0.0× alpha
0.0000
boldest claim

The sentences

highly significantp < 0.00001actually significant
The comparison between PSADT and the primary PSA level also revealed highly significant differences (p < 0.00001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.